180 related articles for article (PubMed ID: 23584743)
1. Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.
Ahmet I; Tae HJ; Brines M; Cerami A; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2013 Jun; 345(3):446-56. PubMed ID: 23584743
[TBL] [Abstract][Full Text] [Related]
2. A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.
Ahmet I; Tae HJ; Juhaszova M; Riordon DR; Boheler KR; Sollott SJ; Brines M; Cerami A; Lakatta EG; Talan MI
Mol Med; 2011; 17(3-4):194-200. PubMed ID: 21170473
[TBL] [Abstract][Full Text] [Related]
3. Helix B surface peptide attenuates diabetic cardiomyopathy via AMPK-dependent autophagy.
Lin C; Zhang M; Zhang Y; Yang K; Hu J; Si R; Zhang G; Gao B; Li X; Xu C; Li C; Hao Q; Guo W
Biochem Biophys Res Commun; 2017 Jan; 482(4):665-671. PubMed ID: 27865838
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
van der Meer P; Lipsic E; Henning RH; Boddeus K; van der Velden J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
J Am Coll Cardiol; 2005 Jul; 46(1):125-33. PubMed ID: 15992646
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Ahmet I; Lakatta EG; Talan MI
Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin.
Ueba H; Brines M; Yamin M; Umemoto T; Ako J; Momomura S; Cerami A; Kawakami M
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14357-62. PubMed ID: 20660739
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
8. Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat.
Hale SL; Sesti C; Kloner RA
J Cardiovasc Pharmacol; 2005 Aug; 46(2):211-5. PubMed ID: 16044033
[TBL] [Abstract][Full Text] [Related]
9. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
[TBL] [Abstract][Full Text] [Related]
10. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
Fiordaliso F; Chimenti S; Staszewsky L; Bai A; Carlo E; Cuccovillo I; Doni M; Mengozzi M; Tonelli R; Ghezzi P; Coleman T; Brines M; Cerami A; Latini R
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2046-51. PubMed ID: 15671158
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.
Moon C; Krawczyk M; Paik D; Coleman T; Brines M; Juhaszova M; Sollott SJ; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2006 Mar; 316(3):999-1005. PubMed ID: 16306273
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats.
Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Marutsuka K; Asada Y; Kangawa K; Eto T
Cardiovasc Res; 2002 Dec; 56(3):373-80. PubMed ID: 12445878
[TBL] [Abstract][Full Text] [Related]
13. Suppression of coronary atherosclerosis by helix B surface Peptide, a nonerythropoietic, tissue-protective compound derived from erythropoietin.
Ueba H; Shiomi M; Brines M; Yamin M; Kobayashi T; Ako J; Momomura S; Cerami A; Kawakami M
Mol Med; 2013 Jul; 19(1):195-202. PubMed ID: 23648638
[TBL] [Abstract][Full Text] [Related]
14. Fenoterol enantiomers do not possess beneficial therapeutic properties of their racemic mixture in the rat model of post myocardial infarction dilated cardiomyopathy.
Ahmet I; Turner T; Lakatta EG; Talan MI
Cardiovasc Drugs Ther; 2012 Apr; 26(2):101-8. PubMed ID: 22328006
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function.
Pessoa FG; Mady C; Fonseca KCB; de Oliveira-Fonoff AM; Salemi VMC; Jordão MR; Fernandes F; Ramires FJA
Can J Physiol Pharmacol; 2018 Jun; 96(6):541-549. PubMed ID: 29120671
[TBL] [Abstract][Full Text] [Related]
17. Survival and cardioprotective benefits of long-term blueberry enriched diet in dilated cardiomyopathy following myocardial infarction in rats.
Ahmet I; Spangler E; Shukitt-Hale B; Joseph JA; Ingram DK; Talan M
PLoS One; 2009 Nov; 4(11):e7975. PubMed ID: 19936253
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
[TBL] [Abstract][Full Text] [Related]
19. An ovine model of postinfarction dilated cardiomyopathy.
Moainie SL; Gorman JH; Guy TS; Bowen FW; Jackson BM; Plappert T; Narula N; St John-Sutton MG; Narula J; Edmunds LH; Gorman RC
Ann Thorac Surg; 2002 Sep; 74(3):753-60. PubMed ID: 12238835
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effectiveness of a single vs multiple doses of erythropoietin after experimental myocardial infarction in rats.
Moon C; Krawczyk M; Lakatta EG; Talan MI
Cardiovasc Drugs Ther; 2006 Aug; 20(4):245-51. PubMed ID: 17019537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
